HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gender differences and pharmacological regulation of angiogenesis induced by synovial fluids in inflammatory arthritis.

Abstract
Several mediators including cytokines, growth factors and metalloproteinases (MMP) modulate pathological angiogenesis associated with inflammatory arthritis. The biological factors underlying sex disparities in the incidence and severity of rheumatic musculoskeletal diseases are only partially understood. We hypothesized that synovial fluids (SFs) from rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients would impact on endothelial biology in a sexually dimorphic fashion. Immune cell counts and levels of pro-angiogenic cytokines found in SFs from RA and PsA patients (n = 17) were higher than in osteoarthritis patients (n = 6). Synovial VEGF concentration was significantly higher in male than in female RA patients. Zymography revealed that SFs comprised solely MMP-9 and MMP-2, with significantly higher MMP-9 levels in male than female RA patients. Using in vitro approaches that mimic the major steps of the angiogenic process, SFs from RA and PsA patients induced endothelial migration and formation of capillary-like structures compared to control. Notably, endothelial cells from female donors displayed enhanced angiogenic response to SFs with respect to males. Treatment with the established anti-angiogenic agent digitoxin prevented activation of focal adhesion kinase and SF-induced in vitro angiogenesis. Thus, despite higher synovial VEGF and MMP-9 levels in male patients, the responsiveness of vascular endothelium to SF priming was higher in females, suggesting that gender differences in angiogenic responses were mainly related to the endothelial genotype. These findings may have implications for pathogenesis and targeted therapies of inflammatory arthritis.
AuthorsChiara Baggio, Carlotta Boscaro, Francesca Oliviero, Lucia Trevisi, Giovanni Ramaschi, Roberta Ramonda, Chiara Bolego, Andrea Cignarella
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 152 Pg. 113181 (Aug 2022) ISSN: 1950-6007 [Electronic] France
PMID35653890 (Publication Type: Journal Article)
CopyrightCopyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Chemical References
  • Cytokines
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinase 9
Topics
  • Arthritis, Psoriatic (drug therapy, metabolism, pathology)
  • Arthritis, Rheumatoid (metabolism)
  • Cytokines (metabolism)
  • Endothelial Cells (metabolism)
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 9 (metabolism)
  • Neovascularization, Pathologic (metabolism)
  • Sex Factors
  • Synovial Fluid (metabolism)
  • Synovial Membrane (pathology)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: